drugset / Trial / NCT06570291
Allogenic Adipose-Derived Mesenchymal Stem Cells for the Treatment of Knee Osteoarthritis
RandomizedParallel-groupDouble-blindTreatment
Summary
Evaluate the efficacy and safety of Allogenic Adipose Tissue-Derived Mesenchymal Stem Cells Therapy
Timeline
- Start
- 2025-02-28
- Primary completion
- 2026-12
- Completion
- 2028-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Sodium Hyaluronate | Other / unclassified | — | Other |
| Subject | mesenchymal stem cells | Cell therapy | — | Other |